University College London, St George's, University of London
[edite no Wikidata]
Patrick John Thompson VallanceFRS[1] (1960)[2] é um doutor em medicina britânico, chefe de pesquisa e desenvolvimento da companhia farmacêutica multinacional britânica GlaxoSmithKline (GSK).[3][4][5]
↑ abAnon (2017). «Dr Patrick Vallance FMedSci FRS». royalsociety.org. London: Royal Society One or more of the preceding sentences incorporates text from the royalsociety.org website where:
“All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License.” --Royal Society Terms, conditions and policies no Wayback Machine (arquivado em 2016-11-11)
↑«Patrick John Thompson VALLANCE». companieshouse.gov.uk. London: Companies House
↑Anon (2015). «Patrick Vallance: Inquisitive and geeky». The BMJ. 350 (mar05 5): h1144–h1144. ISSN 1756-1833. PMID 25742697. doi:10.1136/bmj.h1144
↑Cressey, Daniel (2011). «Traditional drug-discovery model ripe for reform». Nature. 471 (7336): 17–18. ISSN 0028-0836. doi:10.1038/471017a
